BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 27037777)

  • 1. Stimuli-responsive lipid nanotubes in gel formulations for the delivery of doxorubicin.
    Ilbasmis-Tamer S; Unsal H; Tugcu-Demiroz F; Kalaycioglu GD; Degim IT; Aydogan N
    Colloids Surf B Biointerfaces; 2016 Jul; 143():406-414. PubMed ID: 27037777
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chitosan Immobilization on Bio-MOF Nanostructures: A Biocompatible pH-Responsive Nanocarrier for Doxorubicin Release on MCF-7 Cell Lines of Human Breast Cancer.
    Abazari R; Mahjoub AR; Ataei F; Morsali A; Carpenter-Warren CL; Mehdizadeh K; Slawin AMZ
    Inorg Chem; 2018 Nov; 57(21):13364-13379. PubMed ID: 30351060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Facile development of nanocomplex-in-nanoparticles for enhanced loading and selective delivery of doxorubicin to brain.
    Hefnawy A; Khalil IA; El-Sherbiny IM
    Nanomedicine (Lond); 2017 Dec; 12(24):2737-2761. PubMed ID: 29135325
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of pH-responsive alginate/chitosan multilayers coating on delivery efficiency, cellular uptake and biodistribution of mesoporous silica nanoparticles based nanocarriers.
    Feng W; Nie W; He C; Zhou X; Chen L; Qiu K; Wang W; Yin Z
    ACS Appl Mater Interfaces; 2014 Jun; 6(11):8447-60. PubMed ID: 24745551
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Formulation and cytotoxicity of doxorubicin loaded in self-assembled bio-polyelectrolyte microshells.
    Tao X; Chen H; Sun XJ; Chen JF; Roa WH
    Int J Pharm; 2007 May; 336(2):376-81. PubMed ID: 17223293
    [TBL] [Abstract][Full Text] [Related]  

  • 6. pH-sensitive Laponite(®)/doxorubicin/alginate nanohybrids with improved anticancer efficacy.
    Gonçalves M; Figueira P; Maciel D; Rodrigues J; Qu X; Liu C; Tomás H; Li Y
    Acta Biomater; 2014 Jan; 10(1):300-7. PubMed ID: 24075886
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design, Preparation and Evaluation of HPMC-Based PAA or SA Freeze-Dried Scaffolds for Vaginal Delivery of Fluconazole.
    Gafitanu CA; Filip D; Cernatescu C; Rusu D; Tuchilus CG; Macocinschi D; Zaltariov MF
    Pharm Res; 2017 Oct; 34(10):2185-2196. PubMed ID: 28707165
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fabrication of doxorubicin nanoparticles by controlled antisolvent precipitation for enhanced intracellular delivery.
    Tam YT; To KK; Chow AH
    Colloids Surf B Biointerfaces; 2016 Mar; 139():249-58. PubMed ID: 26724466
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acid and reduction stimulated logic "and"-type combinational release mode achieved in DOX-loaded superparamagnetic nanogel.
    Song M; Xue Y; Chen L; Xia X; Zhou Y; Liu L; Yu B; Long S; Huang S; Yu F
    Mater Sci Eng C Mater Biol Appl; 2016 Aug; 65():354-63. PubMed ID: 27157762
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis of Doxorubicin loaded magnetic chitosan nanoparticles for pH responsive targeted drug delivery.
    Unsoy G; Khodadust R; Yalcin S; Mutlu P; Gunduz U
    Eur J Pharm Sci; 2014 Oct; 62():243-50. PubMed ID: 24931189
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dual-purpose Injectable Doxorubicin Conjugated Alginate Gel Containing Polycaprolactone Microparticles for Anti-Cancer and Anti-Inflammatory Therapy.
    Pawar V; Borse V; Thakkar R; Srivastava R
    Curr Drug Deliv; 2018; 15(5):716-726. PubMed ID: 29034837
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bio-responsive alginate-keratin composite nanogels with enhanced drug loading efficiency for cancer therapy.
    Sun Z; Yi Z; Zhang H; Ma X; Su W; Sun X; Li X
    Carbohydr Polym; 2017 Nov; 175():159-169. PubMed ID: 28917852
    [TBL] [Abstract][Full Text] [Related]  

  • 13. pH/Reduction Dual-Responsive Oxidized Alginate-Doxorubicin (mPEG-OAL-DOX/Cys) Prodrug Nanohydrogels: Effect of Complexation with Cyclodextrins.
    Zhou T; Li J; Jia X; Zhao X; Liu P
    Langmuir; 2018 Jan; 34(1):416-424. PubMed ID: 29237263
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chitosan-alginate BSA-gel-capsules for local chemotherapy against drug-resistant breast cancer.
    Shen H; Li F; Wang D; Yang Z; Yao C; Ye Y; Wang X
    Drug Des Devel Ther; 2018; 12():921-934. PubMed ID: 29719378
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chitosan-tripolyphosphate nanoparticles functionalized with a pH-responsive amphiphile improved the in vitro antineoplastic effects of doxorubicin.
    Nogueira-Librelotto DR; Scheeren LE; Vinardell MP; Mitjans M; Rolim CMB
    Colloids Surf B Biointerfaces; 2016 Nov; 147():326-335. PubMed ID: 27543694
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surface charge effect on mucoadhesion of chitosan based nanogels for local anti-colorectal cancer drug delivery.
    Feng C; Li J; Kong M; Liu Y; Cheng XJ; Li Y; Park HJ; Chen XG
    Colloids Surf B Biointerfaces; 2015 Apr; 128():439-447. PubMed ID: 25769283
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of self-forming doxorubicin-loaded polymeric depots as an injectable drug delivery system for liver cancer chemotherapy.
    Nittayacharn P; Nasongkla N
    J Mater Sci Mater Med; 2017 Jul; 28(7):101. PubMed ID: 28534285
    [TBL] [Abstract][Full Text] [Related]  

  • 18. pH-responsive poly (acrylic acid)-gated mesoporous silica and its application in oral colon targeted drug delivery for doxorubicin.
    Tian B; Liu S; Wu S; Lu W; Wang D; Jin L; Hu B; Li K; Wang Z; Quan Z
    Colloids Surf B Biointerfaces; 2017 Jun; 154():287-296. PubMed ID: 28351801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PEGylated and poloxamer-modified chitosan nanoparticles incorporating a lysine-based surfactant for pH-triggered doxorubicin release.
    Scheeren LE; Nogueira DR; Macedo LB; Vinardell MP; Mitjans M; Infante MR; Rolim CM
    Colloids Surf B Biointerfaces; 2016 Feb; 138():117-27. PubMed ID: 26674840
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis, Formulation, and Characterization of Doxorubicin-Loaded Laponite/Oligomeric Hyaluronic Acid-Aminophenylboronic Acid Nanohybrids and Cytological Evaluation against MCF-7 Breast Cancer Cells.
    Yang Y; Li J; Chen F; Qiao S; Li Y; Pan W
    AAPS PharmSciTech; 2019 Nov; 21(1):5. PubMed ID: 31749020
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.